Cytomaite II – Uncovering Prognostic Biomarkers in Leukemia with Explainable AI
AI-compatible platform for automated therapeutic target discovery to overcome acquired drug resistance in leukemia
Development of a machine-learning approach for leukemia cell – mcroenvironment interactions
Funded By Mertelsmann Foundation
The Mertelsmann Foundation has made improving the fight against cancer with the help of innovative methods its main concern. To this end, it brings together cancer research and artificial intelligence. In doing so, it relies on interdisciplinary collaboration between experimental and clinical oncology, artificial intelligence and philosophy.